Probing genetics and biology of human sleep homeostasis
Project Number5R01NS117929-04
Former Number1R01NS117929-01
Contact PI/Project LeaderPTACEK, LOUIS J.
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
Project Summary
Familial Natural ShortSleep (FNSS) is a rare Mendelian form of sleep where affected individuals have a lifelong
requirement for sleep that is significantly less than the average person. These people often sleep 4-6 hours per
night yet report feeling well-rested. In 2009, we reported the first human FNSS trait, identification of the causative
gene/mutation. and characterization of a similarly shortsleep phenotype in modeled mice (and a corresponding
rest-activity phenotype in Drosophila). We have since identified over 90 FNSS probands and have been
expanding these families with phenotyping and DNA banking of additional affected and unaffected family
members. Subsequent whole exome sequencing (WES) identified 2 candidate genes/mutations (1 in each of 2
families). In both cases, we've generated mouse models of the human mutations. Both of these mice also show
shortsleep phenotype as seen in human subjects. Another gene (GRM1) was found to harbor distinct mutations
in 2 different families. A mouse model of one GRM1 allele also shows shortsleep by EEG. These 4 genes
(DEC2, ADRB1, NPSR1, and GRM1) still only explain a minority of the ~30 families that underwent initial WES.
In this proposal, we plan to continue collecting FNSS subjects from existing `unexplained' families and to continue
collecting new probands and their families. Our growing database is an incredible resource for identifying
additional FNSS genes/mutations via whole exome sequencing and whole genome sequencing. Studies of this
growing list of FNSS genes will help us and others to better understand pathways and brain circuits that
contribute to sleep regulation and efficiency. Ultimately, understanding of such biological pathways may lead to
novel targets for developing better drugs to improve sleep quality and efficiency.
Public Health Relevance Statement
Project Narrative
Familial Natural ShortSleep (FNSS) is a rare Mendelian form of sleep where affected individuals have a lifelong
requirement for sleep that is significantly less than the average person. Identification of genes/mutations in these
families will help us understand the biology and molecular basis of sleep. Ultimately, understanding of such
biological pathways may lead to novel targets for developing better drugs to improve sleep quality and efficiency.
NIH Spending Category
No NIH Spending Category available.
Project Terms
ADRB1 geneAccelerationAffectAllelesAmericanBiologicalBiologyBrainCandidate Disease GeneCessation of lifeChronicCodeCollectionDNA DatabasesDNA LibraryDatabasesDetectionDrosophila genusElectroencephalographyEpidemiologyFamilyFamily memberGRM1 geneGenesGeneticGenomeGrantHealthHomeostasisHourHumanHuman BiologyImmunityImpairmentIn VitroIndividualInduced MutationIntronsInvestmentsMaintenanceMassive Parallel SequencingMetabolismMinorityMolecularMorbidity - disease rateMusMutationNucleic Acid Regulatory SequencesOpen Reading FramesPathway interactionsPatient Self-ReportPersonsPharmaceutical PreparationsPhenotypePhysiciansPopulationProteinsRegulationReportingResourcesRestRiskRoleSamplingSleepSleep DeprivationSleep DisordersStreamSurveysTechnologyTemperatureTranslatingUnited States National Institutes of HealthVariantWell in selfWorkautosomecircadianclinical databaseexomeexome sequencinggenome sequencinghuman subjectimprovement on sleepin vivointerestmortalitymouse modelnovelprobandpsychosocialsleep behaviorsleep patternsleep qualitysleep quantitysleep regulationtraitwhole genome
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
01-August-2021
Project End Date
31-July-2026
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$646,190
Direct Costs
$400,118
Indirect Costs
$246,072
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$646,190
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS117929-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS117929-04
Patents
No Patents information available for 5R01NS117929-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS117929-04
Clinical Studies
No Clinical Studies information available for 5R01NS117929-04
News and More
Related News Releases
No news release information available for 5R01NS117929-04
History
No Historical information available for 5R01NS117929-04
Similar Projects
No Similar Projects information available for 5R01NS117929-04